A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
National Cancer Institute (NCI)
Prescient Therapeutics, Ltd.
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
City of Hope Medical Center
Columbia University
City of Hope Medical Center
University College, London
Innate Pharma
4SC AG
Northwestern University
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
University of Nebraska
Genmab
OncoSec Medical Incorporated
Genmab
miRagen Therapeutics, Inc.
Rochester Skin Lymphoma Medical Group, PLLC
European Organisation for Research and Treatment of Cancer - EORTC
Novartis
Novartis
Rochester General Hospital
Fred Hutchinson Cancer Center
miRagen Therapeutics, Inc.
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
University of Chicago
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
Northwestern University
Case Comprehensive Cancer Center
University of Texas Southwestern Medical Center
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
Neumedicines Inc.
Wake Forest University Health Sciences
Memorial Sloan Kettering Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Washington
Fred Hutchinson Cancer Center